{"id":76317,"date":"2026-10-16T22:39:23","date_gmt":"2026-10-16T22:39:23","guid":{"rendered":"https:\/\/www.stocktargetadvisor.com\/blog\/?p=76317"},"modified":"2026-10-16T22:39:23","modified_gmt":"2026-10-16T22:39:23","slug":"us-analyst-updates-october-16th-2026","status":"publish","type":"post","link":"https:\/\/www.stocktargetadvisor.com\/blog\/us-analyst-updates-october-16th-2026\/","title":{"rendered":"US Analyst Updates: October 16th, 2026"},"content":{"rendered":"<h2><a href=\"https:\/\/www.stocktargetadvisor.com\/blog\/?p=76317&amp;preview=true\"><strong>Analyst Ratings (USA)<\/strong><\/a><\/h2>\n<p>American analyst sentiment for October 16, 2026, remained cautious but selectively optimistic, with price target reductions significantly outnumbering increases, reflecting concerns over valuations, slowing economic growth, and corporate earnings. Technology, artificial intelligence, aerospace, defence, and biotechnology continued to attract favourable ratings and new coverage, while energy benefited from renewed investor interest. Conversely, consumer discretionary, chemicals, financial services, and housing-related sectors faced increasing pressure from inflation, elevated borrowing costs, and weaker demand expectations. Overall, analysts appeared to be shifting toward a more defensive investment approach, favouring companies with resilient earnings, strong balance sheets, and sustainable growth prospects amid heightened recession risks.<\/p>\n<p><strong>Updates (415)<\/strong><\/p>\n<p><strong>Abbott Laboratories (ABT)<\/strong> \u2014 TD Cowen maintained its Buy rating with a $135.00 price target.<\/p>\n<p><strong>Absci (ABSI)<\/strong> \u2014 KeyCorp maintained its Overweight rating and raised its price target to $20.00 from $16.00.<\/p>\n<p><strong>ACI Worldwide (ACIW)<\/strong> \u2014 Stephens resumed coverage with an Equal Weight rating and a $56.00 price target.<\/p>\n<p><strong>AeroVironment (AVAV)<\/strong> \u2014 Citigroup initiated coverage with a Buy rating (previously Market Outperform).<\/p>\n<p><strong>AeroVironment (AVAV)<\/strong> \u2014 Macquarie initiated coverage with an Outperform rating and a $210 price target.<\/p>\n<p><strong>Agnico Eagle Mines (AEM)<\/strong> \u2014 Canadian Imperial Bank of Commerce set a $239.00 price target.<\/p>\n<p><strong>Alaska Air Group (ALK)<\/strong> \u2014 UBS Group maintained its Buy rating with a $51.00 price target (previous target $54.00).<\/p>\n<p><strong>Alcoa (AA)<\/strong> \u2014 Wells Fargo &amp; Company maintained its Overweight rating.<\/p>\n<p><strong>Alkermes (ALKS)<\/strong> \u2014 Truist Financial initiated coverage with a Buy rating and a $55.00 price target.<\/p>\n<p><strong>Allied Gold (AAUC)<\/strong> \u2014 Canadian Imperial Bank of Commerce maintained its Outperform rating.<\/p>\n<p><strong>American Airlines Group (AAL)<\/strong> \u2014 UBS Group maintained its Buy rating and lowered its price target to $16.00 from $17.00.<\/p>\n<p><strong>American Water Works (AWK)<\/strong> \u2014 UBS Group maintained its Buy rating and lowered its price target to $153.00 from $162.00.<\/p>\n<p><strong>Applied Aerospace &amp; Defense (AADX)<\/strong> \u2014 Morgan Stanley set a $16.00 price target.<\/p>\n<p><strong>Applied Materials (AMAT)<\/strong> \u2014 Needham &amp; Company LLC maintained its Buy rating and lowered its price target to $580.00 from $740.00.<\/p>\n<p><strong>Aquestive Therapeutics (AQST)<\/strong> \u2014 HC Wainwright maintained its Buy rating with a $10.00 price target.<\/p>\n<p><strong>Arcus Biosciences (RCUS)<\/strong> \u2014 William Blair initiated coverage with an Outperform rating.<\/p>\n<p><strong>Ares Management (ARES)<\/strong> \u2014 Morgan Stanley set a $149.00 price target.<\/p>\n<p><strong>ArriVent BioPharma (AVBP)<\/strong> \u2014 BTIG Research maintained its Buy rating with a $29.00 price target.<\/p>\n<p><strong>Asana (ASAN)<\/strong> \u2014 UBS Group maintained its Neutral rating.<\/p>\n<p><strong>Ascentage Pharma Group International (AAPG)<\/strong> \u2014 William Blair initiated coverage with an Outperform rating.<\/p>\n<p><strong>Ashland (ASH)<\/strong> \u2014 Wells Fargo &amp; Company set a $75.00 price target.<\/p>\n<p><strong>Avalo Therapeutics (AVTX)<\/strong> \u2014 HC Wainwright maintained its Buy rating.<\/p>\n<p><strong>Avino Silver &amp; Gold Mines (ASM)<\/strong> \u2014 Roth Capital upgraded the stock from Neutral to Buy with a $7.00 price target.<\/p>\n<p><strong>B&amp;G Foods (BGS)<\/strong> \u2014 Barclays maintained its Equal Weight rating and lowered its price target to $3.00 from $4.50.<\/p>\n<p><strong>Bandwidth (BAND)<\/strong> \u2014 Morgan Stanley initiated coverage with an Equal Weight rating (previously Underweight) and a $56.00 price target.<\/p>\n<p><strong>Bank of New York Mellon (BNY)<\/strong> \u2014 Keefe, Bruyette &amp; Woods maintained its Outperform rating.<\/p>\n<p><strong>Bank of New York Mellon (BNY)<\/strong> \u2014 New Street Research set a $182.00 price target.<\/p>\n<p><strong>Bank of New York Mellon (BNY)<\/strong> \u2014 Truist Financial maintained its Buy rating and lowered its price target to $165.00 from $172.00.<\/p>\n<p><strong>Bank7 (BSVN)<\/strong> \u2014 Piper Sandler maintained its Overweight rating and raised its price target to $69.00 from $61.00.<\/p>\n<p><strong>Bank7 (BSVN)<\/strong> \u2014 UBS Group maintained its Buy rating.<\/p>\n<p><strong>Barrick Mining (B)<\/strong> \u2014 Canadian Imperial Bank of Commerce downgraded the stock from Sector Outperform to Neutral with a $49.00 price target.<\/p>\n<p><strong>BellRing Brands (BRBR)<\/strong> \u2014 Barclays maintained its Overweight rating and lowered its price target to $12.00 from $14.00.<\/p>\n<p><strong>Bentley Systems (BSY)<\/strong> \u2014 Cantor Fitzgerald maintained its Overweight rating and raised its price target to $42.00 from $37.00.<\/p>\n<p><strong>BeOne Medicines (ONC)<\/strong> \u2014 Morgan Stanley maintained its Overweight rating with a $425.00 price target.<\/p>\n<p><strong>Birkenstock (BIRK)<\/strong> \u2014 Raymond James Financial maintained its Outperform rating and lowered its price target to $42.00 from $52.00.<\/p>\n<p><strong>Blackstone (BX)<\/strong> \u2014 Morgan Stanley maintained its Overweight rating with a $165.00 price target.<\/p>\n<p><strong>Bloom Energy (BE)<\/strong> \u2014 Truist Financial maintained its Hold rating and raised its price target to $240.00 from $218.00.<\/p>\n<p><strong>Boeing (BA)<\/strong> \u2014 Morgan Stanley set a $225.00 price target.<\/p>\n<p><strong>Boot Barn (BOOT)<\/strong> \u2014 Needham &amp; Company LLC initiated coverage with a Buy rating and a $150.00 price target.<\/p>\n<p><strong>Boston Beer (SAM)<\/strong> \u2014 UBS Group maintained its Neutral rating.<\/p>\n<p><strong>Brinker International (EAT)<\/strong> \u2014 Raymond James Financial upgraded the stock from Outperform to Strong Buy with a $260.00 price target.<\/p>\n<p><strong>Brinker International (EAT)<\/strong> \u2014 TD Cowen maintained its Buy rating and lowered its price target to $250.00 from $270.00.<\/p>\n<p><strong>Brookfield Asset Management (BAM)<\/strong> \u2014 Morgan Stanley set a $54.00 price target.<\/p>\n<p><strong>Builders FirstSource (BLDR)<\/strong> \u2014 Oppenheimer maintained its Outperform rating and lowered its price target to $78.00 from $90.00.<\/p>\n<p><strong>Builders FirstSource (BLDR)<\/strong> \u2014 Wells Fargo &amp; Company maintained its Equal Weight rating and lowered its price target to $55.00 from $63.00.<\/p>\n<p><strong>C.H. Robinson Worldwide (CHRW)<\/strong> \u2014 BMO Capital Markets maintained its Market Perform rating and lowered its price target to $160.00 from $190.00.<\/p>\n<p><strong>CACI International (CACI)<\/strong> \u2014 Macquarie initiated coverage with an Outperform rating and a $780 price target.<\/p>\n<p><strong>Camtek (CAMT)<\/strong> \u2014 Needham &amp; Company LLC maintained its Buy rating and lowered its price target to $170.00 from $190.00.<\/p>\n<p><strong>Capital Bancorp (CBNK)<\/strong> \u2014 Stephens changed its rating from Overweight to Equal Weight.<\/p>\n<p><strong>Capri (CPRI)<\/strong> \u2014 Raymond James Financial upgraded the stock from Outperform to Strong Buy with a $20.00 price target.<\/p>\n<p><strong>Cardinal Health (CAH)<\/strong> \u2014 UBS Group maintained its Buy rating and raised its price target to $295.00 from $280.00.<\/p>\n<p><strong>CareTrust REIT (CTRE)<\/strong> \u2014 JPMorgan Chase &amp; Co. initiated coverage with a Neutral rating and a $41.00 price target.<\/p>\n<p><strong>Carlyle Group (CG)<\/strong> \u2014 Morgan Stanley set a $51.00 price target.<\/p>\n<p><strong>CCC Intelligent Solutions Holdings Inc. Common Stock (CCC)<\/strong> \u2014 Barclays maintained its Equal Weight rating and lowered its price target to $7.75 from $8.00.<\/p>\n<p><strong>CCC Intelligent Solutions Holdings Inc. Common Stock (CCC)<\/strong> \u2014 CJS Securities downgraded the stock to Market Perform.<\/p>\n<p><strong>CCC Intelligent Solutions Holdings Inc. Common Stock (CCC)<\/strong> \u2014 Truist Financial set a $7.75 price target.<\/p>\n<p><strong>Cencora (COR)<\/strong> \u2014 UBS Group maintained its Buy rating and lowered its price target to $400.00 from $430.00.<\/p>\n<p><strong>Centerra Gold (CGAU)<\/strong> \u2014 Canadian Imperial Bank of Commerce maintained its Outperform rating.<\/p>\n<p><strong>Certara (CERT)<\/strong> \u2014 KeyCorp maintained its Overweight rating and raised its price target to $12.00 from $9.00.<\/p>\n<p><strong>Charles Schwab (SCHW)<\/strong> \u2014 Barclays maintained its Overweight rating and lowered its price target to $115.00 from $118.00.<\/p>\n<p><strong>Charles Schwab (SCHW)<\/strong> \u2014 Citigroup maintained its Market Outperform rating.<\/p>\n<p><strong>Charles Schwab (SCHW)<\/strong> \u2014 Citizens Jmp maintained its Market Outperform rating with a $120.00 price target.<\/p>\n<p><strong>Charles Schwab (SCHW)<\/strong> \u2014 Deutsche Bank Aktiengesellschaft set a $125.00 price target.<\/p>\n<p><strong>Charles Schwab (SCHW)<\/strong> \u2014 JPMorgan Chase &amp; Co. maintained its Overweight rating and lowered its price target to $147.00 from $150.00.<\/p>\n<p><strong>Charles Schwab (SCHW)<\/strong> \u2014 Jefferies Financial Group set a $120.00 price target.<\/p>\n<p><strong>Charles Schwab (SCHW)<\/strong> \u2014 Keefe, Bruyette &amp; Woods maintained its Outperform rating.<\/p>\n<p><strong>Charles Schwab (SCHW)<\/strong> \u2014 The Goldman Sachs Group maintained its Buy rating with a $117.00 price target.<\/p>\n<p><strong>Charles Schwab (SCHW)<\/strong> \u2014 Truist Financial set a $115.00 price target.<\/p>\n<p><strong>Charles Schwab (SCHW)<\/strong> \u2014 UBS Group maintained its Buy rating and lowered its price target to $109.00 from $113.00.<\/p>\n<p><strong>Charles Schwab (SCHW)<\/strong> \u2014 Wells Fargo &amp; Company maintained its Equal Weight rating and lowered its price target to $103.00 from $105.00.<\/p>\n<p><strong>Chatham Lodging Trust (CLDT)<\/strong> \u2014 Morgan Stanley downgraded the stock to Outperform.<\/p>\n<p><strong>Chatham Lodging Trust (CLDT)<\/strong> \u2014 Stifel Nicolaus maintained its Buy rating with a $15.50 price target (previous target $15.00).<\/p>\n<p><strong>Cheniere Energy (LNG)<\/strong> \u2014 TD Cowen maintained its Buy rating.<\/p>\n<p><strong>Chipotle Mexican Grill (CMG)<\/strong> \u2014 Raymond James Financial maintained its Outperform rating and lowered its price target to $37.00 from $42.50.<\/p>\n<p><strong>Choice Hotels International (CHH)<\/strong> \u2014 Barclays maintained its Underweight rating and raised its price target to $103.00 from $102.00.<\/p>\n<p><strong>ChronoScale Corporation Common Stock (CHRN)<\/strong> \u2014 Compass Point initiated coverage with a Buy rating and a $25.00 price target.<\/p>\n<p><strong>Church &amp; Dwight (CHD)<\/strong> \u2014 Barclays maintained its Underweight rating with a $83.00 price target (previous target $86.00).<\/p>\n<p><strong>Cipher Mining (CIFR)<\/strong> \u2014 Cantor Fitzgerald maintained its Overweight rating and lowered its price target to $19.00 from $28.00.<\/p>\n<p><strong>Citizens Financial Group (CFG)<\/strong> \u2014 Raymond James Financial maintained its Strong-Buy rating.<\/p>\n<p><strong>Cleanspark (CLSK)<\/strong> \u2014 Cantor Fitzgerald maintained its Overweight rating and lowered its price target to $19.00 from $26.00.<\/p>\n<p><strong>Clearwater Paper (CLW)<\/strong> \u2014 Royal Bank Of Canada maintained its Outperform rating and raised its price target to $23.00 from $21.00.<\/p>\n<p><strong>Clorox (CLX)<\/strong> \u2014 Barclays maintained its Underweight rating and lowered its price target to $80.00 from $84.00.<\/p>\n<p><strong>CMS Energy (CMS)<\/strong> \u2014 Barclays maintained its Overweight rating and lowered its price target to $72.00 from $81.00.<\/p>\n<p><strong>CNX Resources (CNX)<\/strong> \u2014 Truist Financial maintained its Hold rating and lowered its price target to $34.00 from $35.00.<\/p>\n<p><strong>Coca-Cola Europacific Partners (CCEP)<\/strong> \u2014 Barclays maintained its Overweight rating and lowered its price target to $112.00 from $119.00.<\/p>\n<p><strong>CocaCola (KO)<\/strong> \u2014 Barclays maintained its Overweight rating and raised its price target to $98.00 from $93.00.<\/p>\n<p><strong>CocaCola (KO)<\/strong> \u2014 TD Cowen maintained its Buy rating.<\/p>\n<p><strong>Commercial Metals (CMC)<\/strong> \u2014 Wells Fargo &amp; Company maintained its Underperform rating with a $70.00 price target.<\/p>\n<p><strong>Compass (COMP)<\/strong> \u2014 Needham &amp; Company LLC maintained its Buy rating and lowered its price target to $12.00 from $17.00.<\/p>\n<p><strong>Comstock Resources (CRK)<\/strong> \u2014 Mizuho maintained its Neutral rating and lowered its price target to $17.00 from $20.00.<\/p>\n<p><strong>Concentra Group Holdings Parent (CON)<\/strong> \u2014 Jefferies Financial Group initiated coverage with a Buy rating and a $47.00 price target.<\/p>\n<p><strong>Construction Partners (ROAD)<\/strong> \u2014 Raymond James Financial maintained its Strong-Buy rating and lowered its price target to $145.00 from $150.00.<\/p>\n<p><strong>CubeSmart (CUBE)<\/strong> \u2014 UBS Group maintained its Neutral rating and lowered its price target to $38.00 from $43.00.<\/p>\n<p><strong>Curtiss-Wright (CW)<\/strong> \u2014 Morgan Stanley set a $625.00 price target.<\/p>\n<p><strong>Cytokinetics (CYTK)<\/strong> \u2014 William Blair initiated coverage with an Outperform rating.<\/p>\n<p><strong>D.R. Horton (DHI)<\/strong> \u2014 Wells Fargo &amp; Company maintained its Equal Weight rating and lowered its price target to $140.00 from $145.00.<\/p>\n<p><strong>Deckers Outdoor (DECK)<\/strong> \u2014 Raymond James Financial set a $105.00 price target with an Outperform rating.<\/p>\n<p><strong>Devon Energy (DVN)<\/strong> \u2014 Mizuho maintained its Outperform rating and lowered its price target to $65.00 from $68.00.<\/p>\n<p><strong>Diversified Energy (DEC)<\/strong> \u2014 Mizuho maintained its Outperform rating and lowered its price target to $29.00 from $32.00.<\/p>\n<p><strong>Doximity (DOCS)<\/strong> \u2014 Raymond James Financial maintained its Outperform rating with a $38.00 price target.<\/p>\n<p><strong>DPC (DPC)<\/strong> \u2014 Morgan Stanley set a $43.00 price target.<\/p>\n<p><strong>DTE Energy (DTE)<\/strong> \u2014 BMO Capital Markets maintained its Market Perform rating and raised its price target to $139.00 from $134.00.<\/p>\n<p><strong>DTE Energy (DTE)<\/strong> \u2014 Barclays maintained its Equal Weight rating and lowered its price target to $135.00 from $154.00.<\/p>\n<p><strong>DTE Energy (DTE)<\/strong> \u2014 Truist Financial maintained its Buy rating and lowered its price target to $150.00 from $160.00.<\/p>\n<p><strong>Duos Technologies Group (DUOT)<\/strong> \u2014 Cantor Fitzgerald maintained its Overweight rating and lowered its price target to $24.00 from $27.00.<\/p>\n<p><strong>Eastman Chemical (EMN)<\/strong> \u2014 JPMorgan Chase &amp; Co. downgraded the stock from Overweight to Neutral with a $66.00 price target.<\/p>\n<p><strong>Eastman Chemical (EMN)<\/strong> \u2014 Wells Fargo &amp; Company set a $68.00 price target.<\/p>\n<p><strong>Echostar (ECHO)<\/strong> \u2014 JPMorgan Chase &amp; Co. resumed coverage with an Overweight rating (previously Underweight) and a $144.00 price target.<\/p>\n<p><strong>Edgewise Therapeutics (EWTX)<\/strong> \u2014 William Blair initiated coverage with an Outperform rating.<\/p>\n<p><strong>Eikon Therapeutics (EIKN)<\/strong> \u2014 HC Wainwright initiated coverage with a Buy rating and a $23.00 price target.<\/p>\n<p><strong>Elanco Animal Health (ELAN)<\/strong> \u2014 The Goldman Sachs Group initiated coverage with a Buy rating and a $32.00 price target.<\/p>\n<p><strong>Elbit Systems (ESLT)<\/strong> \u2014 Morgan Stanley set a $850.00 price target.<\/p>\n<p><strong>Enbridge (ENB)<\/strong> \u2014 TD Securities maintained its Buy rating.<\/p>\n<p><strong>Enerflex (EFXT)<\/strong> \u2014 BMO Capital Markets maintained its Outperform rating.<\/p>\n<p><strong>enGene (ENGN)<\/strong> \u2014 Citigroup downgraded the stock from Market Perform to Hold.<\/p>\n<p><strong>enGene (ENGN)<\/strong> \u2014 HC Wainwright maintained its Buy rating.<\/p>\n<p><strong>Equifax (EFX)<\/strong> \u2014 Oppenheimer downgraded the stock from Outperform to Perform.<\/p>\n<p><strong>Equifax (EFX)<\/strong> \u2014 Royal Bank Of Canada maintained its Outperform rating and lowered its price target to $177.00 from $194.00.<\/p>\n<p><strong>Equity Bancshares (EQBK)<\/strong> \u2014 DA Davidson set a $50.00 price target.<\/p>\n<p><strong>Equity Bancshares (EQBK)<\/strong> \u2014 Piper Sandler maintained its Neutral rating and raised its price target to $53.00 from $52.00.<\/p>\n<p><strong>Equity Bancshares (EQBK)<\/strong> \u2014 Stephens maintained its Overweight rating and lowered its price target to $60.00 from $61.00.<\/p>\n<p><strong>Ericsson (ERIC)<\/strong> \u2014 Danske downgraded the stock from Buy to Hold.<\/p>\n<p><strong>Essential Utilities (WTRG)<\/strong> \u2014 UBS Group maintained its Buy rating and lowered its price target to $47.00 from $49.00.<\/p>\n<p><strong>eToro Group (ETOR)<\/strong> \u2014 KeyCorp maintained its Overweight rating and lowered its price target to $40.00 from $45.00.<\/p>\n<p><strong>Euronet Worldwide (EEFT)<\/strong> \u2014 Stephens resumed coverage with an Equal Weight rating and a $71.00 price target.<\/p>\n<p><strong>Exelon (EXC)<\/strong> \u2014 Truist Financial maintained its Hold rating and lowered its price target to $46.00 from $48.00.<\/p>\n<p><strong>Extra Space Storage (EXR)<\/strong> \u2014 UBS Group maintained its Buy rating and lowered its price target to $152.00 from $163.00.<\/p>\n<p><strong>ExxonMobil (XOM)<\/strong> \u2014 The Goldman Sachs Group set a $169.00 price target.<\/p>\n<p><strong>Fair Isaac (FICO)<\/strong> \u2014 Royal Bank Of Canada maintained its Outperform rating and lowered its price target to $1,045.00 from $1,525.00.<\/p>\n<p><strong>Fermi (FRMI)<\/strong> \u2014 Cantor Fitzgerald maintained its Overweight rating and lowered its price target to $8.00 from $12.00.<\/p>\n<p><strong>Fidelity National Information Services (FIS)<\/strong> \u2014 Cantor Fitzgerald maintained its Overweight rating and lowered its price target to $45.00 from $50.00.<\/p>\n<p><strong>Fidelity National Information Services (FIS)<\/strong> \u2014 Citigroup maintained its Neutral rating and lowered its price target to $39.00 from $45.00.<\/p>\n<p><strong>Fidelity National Information Services (FIS)<\/strong> \u2014 National Bank Financial set a $45.00 price target.<\/p>\n<p><strong>First Financial Bankshares (FFIN)<\/strong> \u2014 Keefe, Bruyette &amp; Woods maintained its Market Perform rating with a $34.00 price target (previous target $35.00).<\/p>\n<p><strong>First Financial Bankshares (FFIN)<\/strong> \u2014 Piper Sandler set a $34.00 price target.<\/p>\n<p><strong>First Horizon (FHN)<\/strong> \u2014 JPMorgan Chase &amp; Co. maintained its Neutral rating and lowered its price target to $26.00 from $27.00.<\/p>\n<p><strong>First Horizon (FHN)<\/strong> \u2014 Morgan Stanley set a $31.00 price target.<\/p>\n<p><strong>First Horizon (FHN)<\/strong> \u2014 Raymond James Financial maintained its Outperform rating and lowered its price target to $27.00 from $28.00.<\/p>\n<p><strong>First Solar (FSLR)<\/strong> \u2014 Jefferies Financial Group maintained its Hold rating with a $199.00 price target.<\/p>\n<p><strong>First Tracks Biotherapeutics (TRAX)<\/strong> \u2014 Leerink Partners maintained its Outperform rating and raised its price target to $90.00 from $70.00.<\/p>\n<p><strong>First Watch Restaurant Group (FWRG)<\/strong> \u2014 Raymond James Financial maintained its Strong-Buy rating and lowered its price target to $18.00 from $20.00.<\/p>\n<p><strong>Fiserv (FISV)<\/strong> \u2014 Cantor Fitzgerald maintained its Neutral rating and lowered its price target to $48.00 from $53.00.<\/p>\n<p><strong>Fiserv (FISV)<\/strong> \u2014 Citigroup maintained its Neutral rating and lowered its price target to $53.00 from $57.00.<\/p>\n<p><strong>Five Below (FIVE)<\/strong> \u2014 UBS Group maintained its Buy rating.<\/p>\n<p><strong>Five9 (FIVN)<\/strong> \u2014 UBS Group maintained its Buy rating and raised its price target to $48.00 from $36.00.<\/p>\n<p><strong>Flywire (FLYW)<\/strong> \u2014 Stephens maintained its Equal Weight rating with a $20.00 price target.<\/p>\n<p><strong>FMC (FMC)<\/strong> \u2014 BMO Capital Markets maintained its Market Perform rating and lowered its price target to $7.50 from $11.00.<\/p>\n<p><strong>FMC (FMC)<\/strong> \u2014 Jefferies Financial Group downgraded the stock from Buy to Hold with a $5.00 price target.<\/p>\n<p><strong>FMC (FMC)<\/strong> \u2014 Royal Bank Of Canada downgraded the stock from Sector Perform to Sell.<\/p>\n<p><strong>Fomento Economico Mexicano (FMX)<\/strong> \u2014 Benchmark upgraded the stock to Overweight.<\/p>\n<p><strong>Fomento Economico Mexicano (FMX)<\/strong> \u2014 JPMorgan Chase &amp; Co. upgraded the stock from Neutral to Overweight with a $151.00 price target.<\/p>\n<p><strong>Forgent Power Solutions (FPS)<\/strong> \u2014 Morgan Stanley set a $45.00 price target.<\/p>\n<p><strong>FOX (FOXA)<\/strong> \u2014 Fox Advisors set a $85.00 price target.<\/p>\n<p><strong>FOX (FOXA)<\/strong> \u2014 Bank of America upgraded the stock from Underperform to Buy with a $85.00 price target.<\/p>\n<p><strong>FOX (FOXA)<\/strong> \u2014 Fox Advisors set a $85.00 price target.<\/p>\n<p><strong>FOX (FOXA)<\/strong> \u2014 Jefferies Financial Group downgraded the stock to Hold.<\/p>\n<p><strong>FOX (FOXA)<\/strong> \u2014 KeyCorp downgraded the stock to Sector Weight.<\/p>\n<p><strong>FOX (FOXA)<\/strong> \u2014 Needham &amp; Company LLC initiated coverage with a Buy rating.<\/p>\n<p><strong>FOX (FOXA)<\/strong> \u2014 Oppenheimer downgraded the stock to Market Perform.<\/p>\n<p><strong>FOX (FOXA)<\/strong> \u2014 Raymond James Financial upgraded the stock to Strong-Buy.<\/p>\n<p><strong>FTAI Aviation (FTAI)<\/strong> \u2014 Macquarie initiated coverage with an Outperform rating and a $305 price target.<\/p>\n<p><strong>FTAI Aviation (FTAI)<\/strong> \u2014 Morgan Stanley maintained its Overweight rating with a $310.00 price target.<\/p>\n<p><strong>GAP (GAP)<\/strong> \u2014 Needham &amp; Company LLC initiated coverage with a Hold rating.<\/p>\n<p><strong>GE Aerospace (GE)<\/strong> \u2014 Sanford C. Bernstein maintained its Outperform rating.<\/p>\n<p><strong>Greif (GEF)<\/strong> \u2014 Raymond James Financial upgraded the stock from Market Perform to Outperform with a $90.00 price target.<\/p>\n<p><strong>Halozyme Therapeutics (HALO)<\/strong> \u2014 Stifel Nicolaus set a $130.00 price target.<\/p>\n<p><strong>Hamilton Lane (HLNE)<\/strong> \u2014 Morgan Stanley set a $118.00 price target.<\/p>\n<p><strong>Heico (HEI)<\/strong> \u2014 Morgan Stanley set a $345.00 price target.<\/p>\n<p><strong>Heritage Insurance (HRTG)<\/strong> \u2014 Raymond James Financial initiated coverage with a Market Perform rating.<\/p>\n<p><strong>Hershey (HSY)<\/strong> \u2014 Barclays maintained its Equal Weight rating and lowered its price target to $178.00 from $200.00.<\/p>\n<p><strong>Hilton Grand Vacations (HGV)<\/strong> \u2014 The Goldman Sachs Group maintained its Neutral rating and lowered its price target to $40.00 from $47.00.<\/p>\n<p><strong>Hilton Worldwide (HLT)<\/strong> \u2014 Barclays maintained its Overweight rating and raised its price target to $384.00 from $368.00.<\/p>\n<p><strong>Hinge Health (HNGE)<\/strong> \u2014 KeyCorp maintained its Overweight rating and raised its price target to $140.00 from $125.00.<\/p>\n<p><strong>Home BancShares (HOMB)<\/strong> \u2014 Piper Sandler maintained its Overweight rating with a $34.00 price target (previous target $36.00).<\/p>\n<p><strong>Home BancShares (HOMB)<\/strong> \u2014 UBS Group maintained its Buy rating.<\/p>\n<p><strong>Hubbell (HUBB)<\/strong> \u2014 Morgan Stanley set a $600.00 price target.<\/p>\n<p><strong>Humacyte (HUMA)<\/strong> \u2014 HC Wainwright maintained its Buy rating.<\/p>\n<p><strong>Humacyte (HUMA)<\/strong> \u2014 Williams Trading set a $1.00 price target.<\/p>\n<p><strong>Hut 8 (HUT)<\/strong> \u2014 Cantor Fitzgerald maintained its Overweight rating and lowered its price target to $151.00 from $180.00.<\/p>\n<p><strong>Hyatt Hotels (H)<\/strong> \u2014 Barclays maintained its Overweight rating and raised its price target to $202.00 from $201.00.<\/p>\n<p><strong>Iamgold (IAG)<\/strong> \u2014 Canadian Imperial Bank of Commerce set a $25.00 price target.<\/p>\n<p><strong>IDEAYA Biosciences (IDYA)<\/strong> \u2014 William Blair initiated coverage with an Outperform rating.<\/p>\n<p><strong>IDEXX Laboratories (IDXX)<\/strong> \u2014 JPMorgan Chase &amp; Co. maintained its Overweight rating and lowered its price target to $750.00 from $775.00.<\/p>\n<p><strong>IDEXX Laboratories (IDXX)<\/strong> \u2014 The Goldman Sachs Group initiated coverage with a Buy rating and a $740.00 price target.<\/p>\n<p><strong>Immunome (IMNM)<\/strong> \u2014 William Blair initiated coverage with an Outperform rating.<\/p>\n<p><strong>Incyte (INCY)<\/strong> \u2014 Raymond James Financial set a $152.00 price target.<\/p>\n<p><strong>Installed Building Products (IBP)<\/strong> \u2014 Wells Fargo &amp; Company maintained its Equal Weight rating and lowered its price target to $195.00 from $240.00.<\/p>\n<p><strong>Interactive Brokers Group (IBKR)<\/strong> \u2014 BMO Capital Markets maintained its Outperform rating with a $100.00 price target (previous target $105.00).<\/p>\n<p><strong>Interactive Brokers Group (IBKR)<\/strong> \u2014 Barclays set a $117.00 price target with an Overweight rating.<\/p>\n<p><strong>Interactive Brokers Group (IBKR)<\/strong> \u2014 Deutsche Bank Aktiengesellschaft set a $104.00 price target with a Buy rating.<\/p>\n<p><strong>International Flavors &amp; Fragrances (IFF)<\/strong> \u2014 Barclays maintained its Overweight rating and raised its price target to $105.00 from $96.00.<\/p>\n<p><strong>Intuitive Machines (LUNR)<\/strong> \u2014 Macquarie initiated coverage with an Outperform rating and a $25 price target.<\/p>\n<p><strong>iRhythm Technologies (IRTC)<\/strong> \u2014 Piper Sandler initiated coverage with an Overweight rating and a $160.00 price target.<\/p>\n<p><strong>J. M. Smucker (SJM)<\/strong> \u2014 Barclays maintained its Equal Weight rating and lowered its price target to $137.00 from $145.00.<\/p>\n<p><strong>J.B. Hunt Transport Services (JBHT)<\/strong> \u2014 Citigroup maintained its Neutral rating and raised its price target to $263.00 from $254.00.<\/p>\n<p><strong>J.B. Hunt Transport Services (JBHT)<\/strong> \u2014 Citizens Jmp maintained its Market Outperform rating with a $300.00 price target.<\/p>\n<p><strong>J.B. Hunt Transport Services (JBHT)<\/strong> \u2014 JPMorgan Chase &amp; Co. maintained its Overweight rating and lowered its price target to $283.00 from $287.00.<\/p>\n<p><strong>J.B. Hunt Transport Services (JBHT)<\/strong> \u2014 Morgan Stanley maintained its Underweight rating with a $195.00 price target.<\/p>\n<p><strong>J.B. Hunt Transport Services (JBHT)<\/strong> \u2014 Raymond James Financial set a $283.00 price target.<\/p>\n<p><strong>J.B. Hunt Transport Services (JBHT)<\/strong> \u2014 Stephens maintained its Overweight rating and lowered its price target to $325.00 from $330.00.<\/p>\n<p><strong>J.B. Hunt Transport Services (JBHT)<\/strong> \u2014 UBS Group maintained its Neutral rating and raised its price target to $273.00 from $264.00.<\/p>\n<p><strong>J.B. Hunt Transport Services (JBHT)<\/strong> \u2014 Wells Fargo &amp; Company maintained its Overweight rating and lowered its price target to $285.00 from $305.00.<\/p>\n<p><strong>J.B. Hunt Transport Services (JBHT)<\/strong> \u2014 William Blair set a $300.00 price target.<\/p>\n<p><strong>Jersey Mike&#8217;s (JMKE)<\/strong> \u2014 Raymond James Financial maintained its Outperform rating and lowered its price target to $26.00 from $29.00.<\/p>\n<p><strong>Jersey Mike&#8217;s (JMKE)<\/strong> \u2014 UBS Group maintained its Outperform rating.<\/p>\n<p><strong>Joby Aviation (JOBY)<\/strong> \u2014 Morgan Stanley set a $10.00 price target.<\/p>\n<p><strong>Johnson &amp; Johnson (JNJ)<\/strong> \u2014 Wells Fargo &amp; Company maintained its Overweight rating and raised its price target to $287.00 from $275.00.<\/p>\n<p><strong>Kardigan (KARD)<\/strong> \u2014 William Blair initiated coverage with an Outperform rating.<\/p>\n<p><strong>Karman Space and Defense (KRMN)<\/strong> \u2014 Macquarie initiated coverage with an Outperform rating and a $65 price target.<\/p>\n<p><strong>KB Home (KBH)<\/strong> \u2014 Wells Fargo &amp; Company maintained its Underweight rating and lowered its price target to $42.00 from $50.00.<\/p>\n<p><strong>Keel Infrastructure (KEEL)<\/strong> \u2014 Cantor Fitzgerald maintained its Overweight rating and lowered its price target to $4.00 from $5.00.<\/p>\n<p><strong>Kimberly-Clark (KMB)<\/strong> \u2014 BNP Paribas Exane maintained its Neutral rating and raised its price target to $110.00 from $101.00.<\/p>\n<p><strong>Kinross Gold (KGC)<\/strong> \u2014 Canadian Imperial Bank of Commerce maintained its Outperform rating with a $34.00 price target.<\/p>\n<p><strong>Klaviyo (KVYO)<\/strong> \u2014 The Goldman Sachs Group downgraded the stock from Buy to Neutral with a $20.00 price target.<\/p>\n<p><strong>Kodiak Gas Services (KGS)<\/strong> \u2014 Royal Bank Of Canada maintained its Outperform rating and lowered its price target to $82.00 from $88.00.<\/p>\n<p><strong>Kodiak Gas Services (KGS)<\/strong> \u2014 UBS Group maintained its Buy rating.<\/p>\n<p><strong>Kontoor Brands (KTB)<\/strong> \u2014 Needham &amp; Company LLC initiated coverage with a Hold rating.<\/p>\n<p><strong>Kraft Heinz (KHC)<\/strong> \u2014 Barclays maintained its Equal Weight rating and lowered its price target to $25.00 from $26.00.<\/p>\n<p><strong>Kratos Defense and Security (KTOS)<\/strong> \u2014 Macquarie initiated coverage with an Outperform rating and a $70 price target.<\/p>\n<p><strong>Leonardo DRS (DRS)<\/strong> \u2014 Morgan Stanley set a $44.00 price target.<\/p>\n<p><strong>Lloyds Banking Group (LYG)<\/strong> \u2014 Royal Bank Of Canada downgraded the stock from Outperform to Sector Perform.<\/p>\n<p><strong>Loar (LOAR)<\/strong> \u2014 Morgan Stanley set a $72.00 price target.<\/p>\n<p><strong>Lockheed Martin (LMT)<\/strong> \u2014 UBS Group maintained its Buy rating with a $653.00 price target.<\/p>\n<p><strong>Louisiana-Pacific (LPX)<\/strong> \u2014 Royal Bank Of Canada maintained its Outperform rating and lowered its price target to $84.00 from $92.00.<\/p>\n<p><strong>ManpowerGroup (MAN)<\/strong> \u2014 JPMorgan Chase &amp; Co. maintained its Neutral rating and lowered its price target to $50.00 from $59.00.<\/p>\n<p><strong>ManpowerGroup (MAN)<\/strong> \u2014 Robert W. Baird maintained its Outperform rating and lowered its price target to $65.00 from $72.00.<\/p>\n<p><strong>ManpowerGroup (MAN)<\/strong> \u2014 UBS Group maintained its Neutral rating and lowered its price target to $48.00 from $56.00.<\/p>\n<p><strong>Marriott International (MAR)<\/strong> \u2014 Barclays maintained its Equal Weight rating and raised its price target to $363.00 from $348.00.<\/p>\n<p><strong>Marsh &amp; McLennan Companies (MRSH)<\/strong> \u2014 Citigroup maintained its Neutral rating and raised its price target to $203.00 from $200.00.<\/p>\n<p><strong>Marsh &amp; McLennan Companies (MRSH)<\/strong> \u2014 Wells Fargo &amp; Company maintained its Equal Weight rating and raised its price target to $197.00 from $183.00.<\/p>\n<p><strong>Martin Marietta Materials (MLM)<\/strong> \u2014 DA Davidson upgraded the stock from Neutral to Buy with a $610.00 price target.<\/p>\n<p><strong>Martin Marietta Materials (MLM)<\/strong> \u2014 Raymond James Financial maintained its Outperform rating and lowered its price target to $640.00 from $660.00.<\/p>\n<p><strong>McKesson (MCK)<\/strong> \u2014 UBS Group maintained its Buy rating and raised its price target to $1,200.00 from $1,080.00.<\/p>\n<p><strong>MDxHealth (MDXH)<\/strong> \u2014 Craig Hallum downgraded the stock from Buy to Hold.<\/p>\n<p><strong>MDxHealth (MDXH)<\/strong> \u2014 Lake Street downgraded the stock from Buy to Hold with a $0.50 price target.<\/p>\n<p><strong>MDxHealth (MDXH)<\/strong> \u2014 Lake Street Capital downgraded the stock from Buy to Hold with a $0.50 price target.<\/p>\n<p><strong>Melco Resorts &amp; Entertainment (MLCO)<\/strong> \u2014 Capital One Financial set a $5.50 price target.<\/p>\n<p><strong>Melco Resorts &amp; Entertainment (MLCO)<\/strong> \u2014 Piper Sandler set a $5.50 price target.<\/p>\n<p><strong>Mercer International (MERC)<\/strong> \u2014 Royal Bank Of Canada maintained its Sector Perform rating and lowered its price target to $0.20 from $0.75.<\/p>\n<p><strong>Methanex (MEOH)<\/strong> \u2014 National Bank Financial maintained its Outperform rating and raised its price target to $79.00 from $70.00.<\/p>\n<p><strong>MGP Ingredients (MGPI)<\/strong> \u2014 Roth Capital maintained its Buy rating and lowered its price target to $30.00 from $32.00.<\/p>\n<p><strong>Mobileye Global (MBLY)<\/strong> \u2014 Citigroup initiated coverage with a Buy rating and a $11.00 price target.<\/p>\n<p><strong>Molson Coors Beverage (TAP)<\/strong> \u2014 Barclays maintained its Underweight rating and lowered its price target to $36.00 from $41.00.<\/p>\n<p><strong>Mondelez International (MDLZ)<\/strong> \u2014 Barclays maintained its Overweight rating and raised its price target to $72.00 from $70.00.<\/p>\n<p><strong>Mondelez International (MDLZ)<\/strong> \u2014 JPMorgan Chase &amp; Co. maintained its Overweight rating and lowered its price target to $71.00 from $72.00.<\/p>\n<p><strong>Moody&#8217;s (MCO)<\/strong> \u2014 Jefferies Financial Group downgraded the stock to Neutral with a $560.00 price target.<\/p>\n<p><strong>Moody&#8217;s (MCO)<\/strong> \u2014 Royal Bank Of Canada maintained its Outperform rating and lowered its price target to $575.00 from $610.00.<\/p>\n<p><strong>Moog (MOG.A)<\/strong> \u2014 Morgan Stanley resumed coverage with an Overweight rating and a $448.00 price target.<\/p>\n<p><strong>Morgan Stanley (MS)<\/strong> \u2014 JPMorgan Chase &amp; Co. maintained its Neutral rating and raised its price target to $198.00 from $195.00.<\/p>\n<p><strong>Mosaic (MOS)<\/strong> \u2014 Barclays maintained its Equal Weight rating and lowered its price target to $22.00 from $26.00.<\/p>\n<p><strong>nCino (NCNO)<\/strong> \u2014 Stephens resumed coverage with an Overweight rating and a $26.00 price target.<\/p>\n<p><strong>Netflix (NFLX)<\/strong> \u2014 BMO Capital Markets maintained its Outperform rating with a $125.00 price target (previous target $135.00).<\/p>\n<p><strong>Netflix (NFLX)<\/strong> \u2014 Rosenblatt Securities maintained its Neutral rating with a $75.00 price target.<\/p>\n<p><strong>Netflix (NFLX)<\/strong> \u2014 Wedbush maintained its Outperform rating and lowered its price target to $90.00 from $105.00.<\/p>\n<p><strong>Neurocrine Biosciences (NBIX)<\/strong> \u2014 Needham &amp; Company LLC maintained its Buy rating with a $204.00 price target.<\/p>\n<p><strong>Newmont (NEM)<\/strong> \u2014 Canadian Imperial Bank of Commerce set a $154.00 price target.<\/p>\n<p><strong>Nexa Resources (NEXA)<\/strong> \u2014 Citigroup maintained its Neutral rating.<\/p>\n<p><strong>Nextpower (NXT)<\/strong> \u2014 Jefferies Financial Group set a $115.00 price target.<\/p>\n<p><strong>NRG Energy (NRG)<\/strong> \u2014 Canadian Imperial Bank of Commerce initiated coverage with an Outperform rating.<\/p>\n<p><strong>Nurix Therapeutics (NRIX)<\/strong> \u2014 HC Wainwright maintained its Buy rating and raised its price target to $36.00 from $34.00.<\/p>\n<p><strong>Oatly Group (OTLY)<\/strong> \u2014 Barclays set a $13.00 price target with an Overweight rating.<\/p>\n<p><strong>Occidental Petroleum (OXY)<\/strong> \u2014 Roth Capital upgraded the stock from Neutral to Buy with a $70.00 price target.<\/p>\n<p><strong>Oceanagold (OGC)<\/strong> \u2014 Canadian Imperial Bank of Commerce maintained its Outperform rating.<\/p>\n<p><strong>ON (ONON)<\/strong> \u2014 Raymond James Financial maintained its Outperform rating and raised its price target to $42.00 from $38.00.<\/p>\n<p><strong>OneMain (OMF)<\/strong> \u2014 Royal Bank Of Canada maintained its Outperform rating and lowered its price target to $71.00 from $73.00.<\/p>\n<p><strong>ONEOK (OKE)<\/strong> \u2014 TD Cowen maintained its Hold rating.<\/p>\n<p><strong>OPKO Health (OPK)<\/strong> \u2014 Barrington Research upgraded the stock from Market Perform to Outperform with a $2.25 price target.<\/p>\n<p><strong>OPKO Health (OPK)<\/strong> \u2014 HC Wainwright maintained its Buy rating.<\/p>\n<p><strong>OPKO Health (OPK)<\/strong> \u2014 Piper Sandler maintained its Overweight rating with a $4.00 price target (previous target $3.00).<\/p>\n<p><strong>OPKO Health (OPK)<\/strong> \u2014 UBS Group maintained its Buy rating with a $4.00 price target.<\/p>\n<p><strong>Opus Genetics (IRD)<\/strong> \u2014 Citizens Jmp maintained its Market Outperform rating with a $17.00 price target.<\/p>\n<p><strong>Owens Corning (OC)<\/strong> \u2014 Wells Fargo &amp; Company maintained its Overweight rating and lowered its price target to $125.00 from $150.00.<\/p>\n<p><strong>Palvella Therapeutics (PVLA)<\/strong> \u2014 Raymond James Financial set a $226.00 price target.<\/p>\n<p><strong>Palvella Therapeutics (PVLA)<\/strong> \u2014 William Blair initiated coverage with an Outperform rating.<\/p>\n<p><strong>Pembina Pipeline (PBA)<\/strong> \u2014 TD Securities maintained its Buy rating.<\/p>\n<p><strong>Penske Automotive Group (PAG)<\/strong> \u2014 UBS Group maintained its Neutral rating with a $212.00 price target.<\/p>\n<p><strong>Planet Labs PBC (PL)<\/strong> \u2014 Morgan Stanley set a $19.00 price target.<\/p>\n<p><strong>Pool (POOL)<\/strong> \u2014 Wells Fargo &amp; Company maintained its Equal Weight rating and lowered its price target to $165.00 from $185.00.<\/p>\n<p><strong>Post (POST)<\/strong> \u2014 Barclays maintained its Overweight rating and lowered its price target to $88.00 from $95.00.<\/p>\n<p><strong>Praxis Precision Medicines (PRAX)<\/strong> \u2014 JPMorgan Chase &amp; Co. initiated coverage with an Overweight rating and a $700.00 price target.<\/p>\n<p><strong>Primo Brands (PRMB)<\/strong> \u2014 Barclays maintained its Overweight rating and lowered its price target to $26.00 from $29.00.<\/p>\n<p><strong>Procore Technologies (PCOR)<\/strong> \u2014 Cantor Fitzgerald maintained its Overweight rating and raised its price target to $70.00 from $65.00.<\/p>\n<p><strong>Procter &amp; Gamble (PG)<\/strong> \u2014 UBS Group maintained its Buy rating.<\/p>\n<p><strong>Progressive (PGR)<\/strong> \u2014 Raymond James Financial maintained its Outperform rating.<\/p>\n<p><strong>Prologis (PLD)<\/strong> \u2014 BMO Capital Markets maintained its Outperform rating.<\/p>\n<p><strong>Prologis (PLD)<\/strong> \u2014 BTIG Research maintained its Buy rating with a $170.00 price target.<\/p>\n<p><strong>Prologis (PLD)<\/strong> \u2014 UBS Group set a $150.00 price target.<\/p>\n<p><strong>Prologis (PLD)<\/strong> \u2014 Williams Trading set a $150.00 price target.<\/p>\n<p><strong>Prudential Financial (PRU)<\/strong> \u2014 Keefe, Bruyette &amp; Woods maintained its Market Perform rating and lowered its price target to $119.00 from $123.00.<\/p>\n<p><strong>PTC Therapeutics (PTCT)<\/strong> \u2014 Truist Financial initiated coverage with a Hold rating and a $62.00 price target.<\/p>\n<p><strong>Public Storage (PSA)<\/strong> \u2014 UBS Group maintained its Neutral rating and lowered its price target to $294.00 from $326.00.<\/p>\n<p><strong>Q2 Holdings (QTWO)<\/strong> \u2014 Stephens resumed coverage with an Overweight rating and a $74 price target.<\/p>\n<p><strong>QumulusAI (QMLS)<\/strong> \u2014 Compass Point initiated coverage with a Buy rating and a $9.00 price target.<\/p>\n<p><strong>QXO (QXO)<\/strong> \u2014 Wells Fargo &amp; Company maintained its Overweight rating and lowered its price target to $15.00 from $16.00.<\/p>\n<p><strong>Rayonier (RYN)<\/strong> \u2014 Royal Bank Of Canada maintained its Sector Perform rating and lowered its price target to $20.00 from $24.00.<\/p>\n<p><strong>RealReal (REAL)<\/strong> \u2014 Roth Capital maintained its Buy rating with a $19.00 price target.<\/p>\n<p><strong>Recursion Pharmaceuticals (RXRX)<\/strong> \u2014 Morgan Stanley set a $5.90 price target.<\/p>\n<p><strong>Repay (RPAY)<\/strong> \u2014 Canaccord Genuity Group maintained its Buy rating with a $8.00 price target.<\/p>\n<p><strong>Revolution Medicines (RVMD)<\/strong> \u2014 William Blair initiated coverage with an Outperform rating (previously Market Perform).<\/p>\n<p><strong>Revolve Group (RVLV)<\/strong> \u2014 Raymond James Financial maintained its Outperform rating and lowered its price target to $25.00 from $28.00.<\/p>\n<p><strong>Rhythm Pharmaceuticals (RYTM)<\/strong> \u2014 William Blair initiated coverage with an Outperform rating.<\/p>\n<p><strong>Rocket Lab (RKLB)<\/strong> \u2014 Citigroup maintained its Market Outperform rating.<\/p>\n<p><strong>Rocket Lab (RKLB)<\/strong> \u2014 Citizens Jmp maintained its Market Outperform rating and lowered its price target to $90.00 from $130.00.<\/p>\n<p><strong>Rocket Lab (RKLB)<\/strong> \u2014 Needham &amp; Company LLC maintained its Buy rating with a $120.00 price target.<\/p>\n<p><strong>Rockwell Automation (ROK)<\/strong> \u2014 Morgan Stanley set a $520.00 price target.<\/p>\n<p><strong>Royal Gold (RGLD)<\/strong> \u2014 Canadian Imperial Bank of Commerce set a $305.00 price target.<\/p>\n<p><strong>S&amp;P Global (SPGI)<\/strong> \u2014 Jefferies Financial Group maintained its Buy rating with a $490.00 price target.<\/p>\n<p><strong>Schrodinger (SDGR)<\/strong> \u2014 KeyCorp maintained its Overweight rating and raised its price target to $32.00 from $20.00.<\/p>\n<p><strong>Seagate Technology (STX)<\/strong> \u2014 Wells Fargo &amp; Company maintained its Overweight rating and lowered its price target to $865.00 from $1,180.00.<\/p>\n<p><strong>Semtech (SMTC)<\/strong> \u2014 DA Davidson set a $230.00 price target.<\/p>\n<p><strong>Semtech (SMTC)<\/strong> \u2014 Morgan Stanley set a $205.00 price target.<\/p>\n<p><strong>Semtech (SMTC)<\/strong> \u2014 Northland Capital upgraded the stock from Market Perform to Outperform with a $186 price target.<\/p>\n<p><strong>Semtech (SMTC)<\/strong> \u2014 Northland Securities upgraded the stock from Market Perform to Outperform with a $186.00 price target.<\/p>\n<p><strong>Semtech (SMTC)<\/strong> \u2014 Stifel Nicolaus maintained its Buy rating and lowered its price target to $200.00 from $220.00.<\/p>\n<p><strong>Semtech (SMTC)<\/strong> \u2014 TD Cowen maintained its Buy rating with a $215.00 price target.<\/p>\n<p><strong>Sensei Biotherapeutics (FTH)<\/strong> \u2014 William Blair initiated coverage with an Outperform rating.<\/p>\n<p><strong>ServiceNow (NOW)<\/strong> \u2014 Piper Sandler maintained its Overweight rating and raised its price target to $175.00 from $140.00.<\/p>\n<p><strong>Shoals Technologies Group (SHLS)<\/strong> \u2014 Mizuho maintained its Neutral rating and lowered its price target to $10.00 from $11.00.<\/p>\n<p><strong>Shopify (SHOP)<\/strong> \u2014 Royal Bank Of Canada maintained its Outperform rating with a $200.00 price target (previous target $180.00).<\/p>\n<p><strong>Six Flags Entertainment (FUN)<\/strong> \u2014 UBS Group maintained its Buy rating and lowered its price target to $18.00 from $27.00.<\/p>\n<p><strong>Skydance (SKYD)<\/strong> \u2014 Sanford C. Bernstein maintained its Underperform rating with a $6.00 price target (previous target $12.00).<\/p>\n<p><strong>Skydance (SKYD)<\/strong> \u2014 Stephens maintained its Buy rating.<\/p>\n<p><strong>Smith Douglas Homes (SDHC)<\/strong> \u2014 Wells Fargo &amp; Company maintained its Equal Weight rating and lowered its price target to $10.00 from $14.00.<\/p>\n<p><strong>Smurfit Westrock (SW)<\/strong> \u2014 Royal Bank Of Canada maintained its Outperform rating and lowered its price target to $55.00 from $60.00.<\/p>\n<p><strong>Southern (SO)<\/strong> \u2014 Barclays maintained its Equal Weight rating and lowered its price target to $92.00 from $101.00.<\/p>\n<p><strong>Southwest Airlines (LUV)<\/strong> \u2014 UBS Group maintained its Buy rating and lowered its price target to $52.00 from $53.00.<\/p>\n<p><strong>SpaceX (SPCX)<\/strong> \u2014 Evercore maintained its Outperform rating with a $275.00 price target.<\/p>\n<p><strong>Stanley Black &amp; Decker (SWK)<\/strong> \u2014 Wells Fargo &amp; Company maintained its Equal Weight rating and lowered its price target to $90.00 from $95.00.<\/p>\n<p><strong>State Street (STT)<\/strong> \u2014 Citigroup maintained its Buy rating and lowered its price target to $190.00 from $212.00.<\/p>\n<p><strong>StepStone Group (STEP)<\/strong> \u2014 Morgan Stanley set a $61.00 price target.<\/p>\n<p><strong>Strategy (MSTR)<\/strong> \u2014 Cantor Fitzgerald maintained its Overweight rating and raised its price target to $208.00 from $186.00.<\/p>\n<p><strong>Super Micro Computer (SMCI)<\/strong> \u2014 Rosenblatt Securities maintained its Buy rating with a $51.00 price target.<\/p>\n<p><strong>Sutro Biopharma (STRO)<\/strong> \u2014 HC Wainwright maintained its Buy rating.<\/p>\n<p><strong>Sylvamo (SLVM)<\/strong> \u2014 Royal Bank Of Canada maintained its Sector Perform rating and lowered its price target to $35.00 from $46.00.<\/p>\n<p><strong>Taiwan Semiconductor Manufacturing (TSM)<\/strong> \u2014 Barclays maintained its Overweight rating and raised its price target to $670.00 from $665.00.<\/p>\n<p><strong>Taiwan Semiconductor Manufacturing (TSM)<\/strong> \u2014 DA Davidson maintained its Buy rating with a $500.00 price target.<\/p>\n<p><strong>Talen Energy (TLN)<\/strong> \u2014 CIBC initiated coverage with a Sector Outperform rating and a $499 price target.<\/p>\n<p><strong>Tango Therapeutics (TNGX)<\/strong> \u2014 William Blair initiated coverage with an Outperform rating.<\/p>\n<p><strong>Tapestry (TPR)<\/strong> \u2014 Raymond James Financial maintained its Outperform rating and lowered its price target to $140.00 from $165.00.<\/p>\n<p><strong>TC Energy (TRP)<\/strong> \u2014 TD Securities maintained its Buy rating.<\/p>\n<p><strong>Telecom Argentina Stet &#8211; France Telecom (TEO)<\/strong> \u2014 Santander initiated coverage with an Outperform rating.<\/p>\n<p><strong>Tenet Healthcare (THC)<\/strong> \u2014 Guggenheim maintained its Buy rating and raised its price target to $307.00 from $283.00.<\/p>\n<p><strong>TeraWulf (WULF)<\/strong> \u2014 Cantor Fitzgerald maintained its Overweight rating and lowered its price target to $30.00 from $37.00.<\/p>\n<p><strong>Texas Roadhouse (TXRH)<\/strong> \u2014 TD Cowen maintained its Buy rating and lowered its price target to $195.00 from $230.00.<\/p>\n<p><strong>Textron (TXT)<\/strong> \u2014 Morgan Stanley set a $86.00 price target.<\/p>\n<p><strong>The Goldman Sachs Group (GS)<\/strong> \u2014 JPMorgan Chase &amp; Co. maintained its Neutral rating and raised its price target to $970.00 from $955.00.<\/p>\n<p><strong>The Hain Celestial Group (HAIN)<\/strong> \u2014 Barclays maintained its Underweight rating and lowered its price target to $0.30 from $0.50.<\/p>\n<p><strong>The PNC Financial Services Group (PNC)<\/strong> \u2014 Keefe, Bruyette &amp; Woods maintained its Market Perform rating and lowered its price target to $250.00 from $260.00.<\/p>\n<p><strong>The PNC Financial Services Group (PNC)<\/strong> \u2014 Oppenheimer maintained its Outperform rating and raised its price target to $269.00 from $263.00.<\/p>\n<p><strong>The PNC Financial Services Group (PNC)<\/strong> \u2014 Raymond James Financial maintained its Outperform rating and lowered its price target to $255.00 from $275.00.<\/p>\n<p><strong>The PNC Financial Services Group (PNC)<\/strong> \u2014 Royal Bank Of Canada maintained its Outperform rating and lowered its price target to $250.00 from $273.00.<\/p>\n<p><strong>The PNC Financial Services Group (PNC)<\/strong> \u2014 TD Cowen maintained its Hold rating and lowered its price target to $240.00 from $245.00.<\/p>\n<p><strong>TKO Group (TKO)<\/strong> \u2014 Susquehanna maintained its Positive rating and lowered its price target to $224.00 from $235.00.<\/p>\n<p><strong>TotalEnergies (TTE)<\/strong> \u2014 Mizuho set a $108.00 price target.<\/p>\n<p><strong>TransUnion (TRU)<\/strong> \u2014 Royal Bank Of Canada maintained its Outperform rating and lowered its price target to $92.00 from $100.00.<\/p>\n<p><strong>Travelers Companies (TRV)<\/strong> \u2014 BMO Capital Markets maintained its Market Perform rating.<\/p>\n<p><strong>Travelers Companies (TRV)<\/strong> \u2014 Citigroup maintained its Neutral rating.<\/p>\n<p><strong>Twilio (TWLO)<\/strong> \u2014 BTIG Research maintained its Buy rating and raised its price target to $315.00 from $285.00.<\/p>\n<p><strong>U.S. Bancorp (USB)<\/strong> \u2014 Citigroup maintained its Buy rating and lowered its price target to $70.00 from $72.00.<\/p>\n<p><strong>U.S. Bancorp (USB)<\/strong> \u2014 DA Davidson maintained its Buy rating with a $73.00 price target.<\/p>\n<p><strong>U.S. Bancorp (USB)<\/strong> \u2014 Morgan Stanley set a $68.00 price target.<\/p>\n<p><strong>U.S. Bancorp (USB)<\/strong> \u2014 Oppenheimer maintained its Outperform rating and raised its price target to $73.00 from $72.00.<\/p>\n<p><strong>U.S. Bancorp (USB)<\/strong> \u2014 Royal Bank Of Canada maintained its Outperform rating and lowered its price target to $65.00 from $68.00.<\/p>\n<p><strong>Uber Technologies (UBER)<\/strong> \u2014 Guggenheim maintained its Buy rating with a $125.00 price target.<\/p>\n<p><strong>United Airlines (UAL)<\/strong> \u2014 UBS Group maintained its Buy rating and lowered its price target to $139.00 from $146.00.<\/p>\n<p><strong>UnitedHealth Group (UNH)<\/strong> \u2014 HC Wainwright set a $500.00 price target.<\/p>\n<p><strong>UnitedHealth Group (UNH)<\/strong> \u2014 JPMorgan Chase &amp; Co. maintained its Overweight rating and raised its price target to $524.00 from $516.00.<\/p>\n<p><strong>UnitedHealth Group (UNH)<\/strong> \u2014 Stephens set a $500.00 price target.<\/p>\n<p><strong>Urban Outfitters (URBN)<\/strong> \u2014 Needham &amp; Company LLC initiated coverage with a Buy rating and a $100.00 price target.<\/p>\n<p><strong>Vale (VALE)<\/strong> \u2014 Deutsche Bank Aktiengesellschaft set a $15.00 price target.<\/p>\n<p><strong>Varonis Systems (VRNS)<\/strong> \u2014 Cantor Fitzgerald maintained its Overweight rating.<\/p>\n<p><strong>Varonis Systems (VRNS)<\/strong> \u2014 Citigroup maintained its Neutral rating and raised its price target to $49.75 from $45.00.<\/p>\n<p><strong>Varonis Systems (VRNS)<\/strong> \u2014 DA Davidson changed its rating from Buy to Neutral with a $49.75 price target (previous target $55.00).<\/p>\n<p><strong>Varonis Systems (VRNS)<\/strong> \u2014 Jefferies Financial Group changed its rating from Buy to Hold with a $49.75 price target (previous target $60.00).<\/p>\n<p><strong>Varonis Systems (VRNS)<\/strong> \u2014 Needham &amp; Company LLC changed its rating from Buy to Hold.<\/p>\n<p><strong>Varonis Systems (VRNS)<\/strong> \u2014 Piper Sandler changed its rating from Overweight to Neutral with a $49.75 price target (previous target $58.00).<\/p>\n<p><strong>Varonis Systems (VRNS)<\/strong> \u2014 Robert W. Baird maintained its Neutral rating and raised its price target to $50.00 from $45.00.<\/p>\n<p><strong>Varonis Systems (VRNS)<\/strong> \u2014 Rosenblatt Securities changed its rating from Buy to Neutral with a $49.75 price target (previous target $55.00).<\/p>\n<p><strong>Varonis Systems (VRNS)<\/strong> \u2014 Royal Bank Of Canada downgraded the stock from Outperform to Sector Perform with a $49.75 price target.<\/p>\n<p><strong>Varonis Systems (VRNS)<\/strong> \u2014 TD Cowen changed its rating from Buy to Hold with a $49.75 price target (previous target $56.00).<\/p>\n<p><strong>Varonis Systems (VRNS)<\/strong> \u2014 Wedbush maintained its Neutral rating and raised its price target to $49.75 from $46.00.<\/p>\n<p><strong>Varonis Systems (VRNS)<\/strong> \u2014 Wells Fargo &amp; Company changed its rating from Overweight to Equal Weight with a $49.75 price target (previous target $53.00).<\/p>\n<p><strong>Venture Global (VG)<\/strong> \u2014 Sanford C. Bernstein maintained its Market Perform rating with a $14.00 price target.<\/p>\n<p><strong>Verastem (VSTM)<\/strong> \u2014 Benchmark maintained its Buy rating.<\/p>\n<p><strong>Verastem (VSTM)<\/strong> \u2014 Mizuho maintained its Outperform rating and raised its price target to $14.00 from $13.00.<\/p>\n<p><strong>Vertiv (VRT)<\/strong> \u2014 Morgan Stanley set a $330.00 price target.<\/p>\n<p><strong>Victoria&#8217;s Secret &amp; Co. (VSXY)<\/strong> \u2014 Needham &amp; Company LLC initiated coverage with a Buy rating and a $106.00 price target.<\/p>\n<p><strong>Victory Capital (VCTR)<\/strong> \u2014 JPMorgan Chase &amp; Co. maintained its Neutral rating and raised its price target to $120.00 from $101.00.<\/p>\n<p><strong>VinFast Auto (VFS)<\/strong> \u2014 Chardan Capital maintained its Buy rating with a $5.50 price target.<\/p>\n<p><strong>Voyager Technologies (VOYG)<\/strong> \u2014 Morgan Stanley set a $36.00 price target.<\/p>\n<p><strong>VSE (VSEC)<\/strong> \u2014 Morgan Stanley set a $215.00 price target.<\/p>\n<p><strong>Vulcan Materials (VMC)<\/strong> \u2014 B. Riley Financial maintained its Buy rating.<\/p>\n<p><strong>Vulcan Materials (VMC)<\/strong> \u2014 Raymond James Financial maintained its Outperform rating and lowered its price target to $308.00 from $320.00.<\/p>\n<p><strong>Walker &amp; Dunlop (WD)<\/strong> \u2014 Citigroup maintained its Market Outperform rating.<\/p>\n<p><strong>Walker &amp; Dunlop (WD)<\/strong> \u2014 Citizens Jmp maintained its Market Outperform rating and lowered its price target to $50.00 from $55.00.<\/p>\n<p><strong>Walt Disney (DIS)<\/strong> \u2014 Citigroup maintained its Buy rating and raised its price target to $140.00 from $135.00.<\/p>\n<p><strong>WAVE Life Sciences (WVE)<\/strong> \u2014 William Blair initiated coverage with an Outperform rating.<\/p>\n<p><strong>Waystar (WAY)<\/strong> \u2014 KeyCorp maintained its Overweight rating and raised its price target to $35.00 from $30.00.<\/p>\n<p><strong>WEC Energy Group (WEC)<\/strong> \u2014 BMO Capital Markets maintained its Market Perform rating.<\/p>\n<p><strong>WEC Energy Group (WEC)<\/strong> \u2014 Stephens set a $109.00 price target.<\/p>\n<p><strong>WEC Energy Group (WEC)<\/strong> \u2014 Truist Financial maintained its Hold rating and lowered its price target to $113.00 from $114.00.<\/p>\n<p><strong>West Fraser Timber (WFG)<\/strong> \u2014 Royal Bank Of Canada maintained its Outperform rating and lowered its price target to $81.00 from $83.00.<\/p>\n<p><strong>Westamerica Bancorporation (WABC)<\/strong> \u2014 Keefe, Bruyette &amp; Woods maintained its Market Perform rating and raised its price target to $65.00 from $64.00.<\/p>\n<p><strong>Western Digital (WDC)<\/strong> \u2014 Wells Fargo &amp; Company maintained its Overweight rating and lowered its price target to $450.00 from $730.00.<\/p>\n<p><strong>Westlake (WLK)<\/strong> \u2014 JPMorgan Chase &amp; Co. maintained its Neutral rating and lowered its price target to $65.00 from $80.00.<\/p>\n<p><strong>Weyerhaeuser (WY)<\/strong> \u2014 Royal Bank Of Canada maintained its Outperform rating and lowered its price target to $25.00 from $30.00.<\/p>\n<p><strong>Whirlpool (WHR)<\/strong> \u2014 Wells Fargo &amp; Company maintained its Equal Weight rating and lowered its price target to $30.00 from $39.00.<\/p>\n<p><strong>WillScot (WSC)<\/strong> \u2014 UBS Group maintained its Neutral rating and lowered its price target to $18.00 from $29.00.<\/p>\n<p><strong>Wingstop (WING)<\/strong> \u2014 Citigroup maintained its Buy rating and lowered its price target to $191.00 from $208.00.<\/p>\n<p><strong>Wise Group (WSE)<\/strong> \u2014 JPMorgan Chase &amp; Co. maintained its Overweight rating and raised its price target to $17.70 from $17.30.<\/p>\n<p><strong>Workday (WDAY)<\/strong> \u2014 BTIG Research maintained its Neutral rating.<\/p>\n<p><strong>Workday (WDAY)<\/strong> \u2014 KeyBanc downgraded the stock from Overweight to Sector Weight.<\/p>\n<p><strong>Zeta Global (ZETA)<\/strong> \u2014 The Goldman Sachs Group upgraded the stock from Neutral to Buy with a $45.00 price target.<\/p>\n<p><strong>Zillow Group (Z)<\/strong> \u2014 Needham &amp; Company LLC maintained its Hold rating.<\/p>\n<p><strong>Zoetis (ZTS)<\/strong> \u2014 The Goldman Sachs Group initiated coverage with a Neutral rating (previously Buy) and a $74.00 price target.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Analyst Ratings (USA) American analyst sentiment for October 16, 2026, remained cautious but selectively optimistic, with price target reductions significantly outnumbering increases, reflecting concerns&hellip;<\/p>\n","protected":false},"author":3,"featured_media":76327,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[1],"tags":[],"class_list":["post-76317","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-blog"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v19.4 (Yoast SEO v21.4) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>US Analyst Updates: October 16th, 2026 | Stock Target Advisor<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.stocktargetadvisor.com\/blog\/us-analyst-updates-october-16th-2026\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"US Analyst Updates: October 16th, 2026\" \/>\n<meta property=\"og:description\" content=\"Analyst Ratings (USA) American analyst sentiment for October 16, 2026, remained cautious but selectively optimistic, with price target reductions significantly outnumbering increases, reflecting concerns&hellip;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.stocktargetadvisor.com\/blog\/us-analyst-updates-october-16th-2026\/\" \/>\n<meta property=\"og:site_name\" content=\"Stock Target Advisor\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/StockTargetAdvisor\/\" \/>\n<meta property=\"article:published_time\" content=\"2026-10-16T22:39:23+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.stocktargetadvisor.com\/blog\/wp-content\/uploads\/2026\/10\/U.S.-Analyst-Updates-on-Wall-Street.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1672\" \/>\n\t<meta property=\"og:image:height\" content=\"941\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"STA Research\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@AdvisorTarget\" \/>\n<meta name=\"twitter:site\" content=\"@AdvisorTarget\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"STA Research\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"29 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/us-analyst-updates-october-16th-2026\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/us-analyst-updates-october-16th-2026\/\"},\"author\":{\"name\":\"STA Research\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/person\/e15ebb81d4f6861fcecbe1abc54e1cae\"},\"headline\":\"US Analyst Updates: October 16th, 2026\",\"datePublished\":\"2026-10-16T22:39:23+00:00\",\"dateModified\":\"2026-10-16T22:39:23+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/us-analyst-updates-october-16th-2026\/\"},\"wordCount\":5982,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#organization\"},\"articleSection\":[\"Market News &amp; Insights\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/www.stocktargetadvisor.com\/blog\/us-analyst-updates-october-16th-2026\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/us-analyst-updates-october-16th-2026\/\",\"url\":\"https:\/\/www.stocktargetadvisor.com\/blog\/us-analyst-updates-october-16th-2026\/\",\"name\":\"US Analyst Updates: October 16th, 2026 | Stock Target Advisor\",\"isPartOf\":{\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#website\"},\"datePublished\":\"2026-10-16T22:39:23+00:00\",\"dateModified\":\"2026-10-16T22:39:23+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/us-analyst-updates-october-16th-2026\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.stocktargetadvisor.com\/blog\/us-analyst-updates-october-16th-2026\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/us-analyst-updates-october-16th-2026\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.stocktargetadvisor.com\/blog\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"US Analyst Updates: October 16th, 2026\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#website\",\"url\":\"https:\/\/www.stocktargetadvisor.com\/blog\/\",\"name\":\"Stock Target Advisor\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.stocktargetadvisor.com\/blog\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#organization\",\"name\":\"Stock Target Advisor\",\"alternateName\":\"STA\",\"url\":\"https:\/\/www.stocktargetadvisor.com\/blog\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/logo\/image\/\",\"url\":\"http:\/\/stocktargetadvisor.com\/wp-content\/uploads\/2019\/10\/STAlogo.jpeg\",\"contentUrl\":\"http:\/\/stocktargetadvisor.com\/wp-content\/uploads\/2019\/10\/STAlogo.jpeg\",\"width\":\"225\",\"height\":\"225\",\"caption\":\"Stock Target Advisor\"},\"image\":{\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/StockTargetAdvisor\/\",\"https:\/\/twitter.com\/AdvisorTarget\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/person\/e15ebb81d4f6861fcecbe1abc54e1cae\",\"name\":\"STA Research\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/13a95c75b44f95ead23f47f0bf10667e57b44ec5150180c8a39a39361cf56169?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/13a95c75b44f95ead23f47f0bf10667e57b44ec5150180c8a39a39361cf56169?s=96&d=mm&r=g\",\"caption\":\"STA Research\"},\"description\":\"STA Research (StockTargetAdvisor.com) is a independent Investment Research company that specializes in stock forecasting and analysis with integrated AI, based on our platform stocktargetadvisor.com, EST 2007.\",\"url\":\"https:\/\/www.stocktargetadvisor.com\/blog\/author\/sta-research\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"US Analyst Updates: October 16th, 2026 | Stock Target Advisor","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.stocktargetadvisor.com\/blog\/us-analyst-updates-october-16th-2026\/","og_locale":"en_US","og_type":"article","og_title":"US Analyst Updates: October 16th, 2026","og_description":"Analyst Ratings (USA) American analyst sentiment for October 16, 2026, remained cautious but selectively optimistic, with price target reductions significantly outnumbering increases, reflecting concerns&hellip;","og_url":"https:\/\/www.stocktargetadvisor.com\/blog\/us-analyst-updates-october-16th-2026\/","og_site_name":"Stock Target Advisor","article_publisher":"https:\/\/www.facebook.com\/StockTargetAdvisor\/","article_published_time":"2026-10-16T22:39:23+00:00","og_image":[{"width":1672,"height":941,"url":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-content\/uploads\/2026\/10\/U.S.-Analyst-Updates-on-Wall-Street.png","type":"image\/png"}],"author":"STA Research","twitter_card":"summary_large_image","twitter_creator":"@AdvisorTarget","twitter_site":"@AdvisorTarget","twitter_misc":{"Written by":"STA Research","Est. reading time":"29 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/us-analyst-updates-october-16th-2026\/#article","isPartOf":{"@id":"https:\/\/www.stocktargetadvisor.com\/blog\/us-analyst-updates-october-16th-2026\/"},"author":{"name":"STA Research","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/person\/e15ebb81d4f6861fcecbe1abc54e1cae"},"headline":"US Analyst Updates: October 16th, 2026","datePublished":"2026-10-16T22:39:23+00:00","dateModified":"2026-10-16T22:39:23+00:00","mainEntityOfPage":{"@id":"https:\/\/www.stocktargetadvisor.com\/blog\/us-analyst-updates-october-16th-2026\/"},"wordCount":5982,"commentCount":0,"publisher":{"@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#organization"},"articleSection":["Market News &amp; Insights"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/www.stocktargetadvisor.com\/blog\/us-analyst-updates-october-16th-2026\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/us-analyst-updates-october-16th-2026\/","url":"https:\/\/www.stocktargetadvisor.com\/blog\/us-analyst-updates-october-16th-2026\/","name":"US Analyst Updates: October 16th, 2026 | Stock Target Advisor","isPartOf":{"@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#website"},"datePublished":"2026-10-16T22:39:23+00:00","dateModified":"2026-10-16T22:39:23+00:00","breadcrumb":{"@id":"https:\/\/www.stocktargetadvisor.com\/blog\/us-analyst-updates-october-16th-2026\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.stocktargetadvisor.com\/blog\/us-analyst-updates-october-16th-2026\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/us-analyst-updates-october-16th-2026\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.stocktargetadvisor.com\/blog\/"},{"@type":"ListItem","position":2,"name":"US Analyst Updates: October 16th, 2026"}]},{"@type":"WebSite","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#website","url":"https:\/\/www.stocktargetadvisor.com\/blog\/","name":"Stock Target Advisor","description":"","publisher":{"@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.stocktargetadvisor.com\/blog\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#organization","name":"Stock Target Advisor","alternateName":"STA","url":"https:\/\/www.stocktargetadvisor.com\/blog\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/logo\/image\/","url":"http:\/\/stocktargetadvisor.com\/wp-content\/uploads\/2019\/10\/STAlogo.jpeg","contentUrl":"http:\/\/stocktargetadvisor.com\/wp-content\/uploads\/2019\/10\/STAlogo.jpeg","width":"225","height":"225","caption":"Stock Target Advisor"},"image":{"@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/StockTargetAdvisor\/","https:\/\/twitter.com\/AdvisorTarget"]},{"@type":"Person","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/person\/e15ebb81d4f6861fcecbe1abc54e1cae","name":"STA Research","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/13a95c75b44f95ead23f47f0bf10667e57b44ec5150180c8a39a39361cf56169?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/13a95c75b44f95ead23f47f0bf10667e57b44ec5150180c8a39a39361cf56169?s=96&d=mm&r=g","caption":"STA Research"},"description":"STA Research (StockTargetAdvisor.com) is a independent Investment Research company that specializes in stock forecasting and analysis with integrated AI, based on our platform stocktargetadvisor.com, EST 2007.","url":"https:\/\/www.stocktargetadvisor.com\/blog\/author\/sta-research\/"}]}},"_links":{"self":[{"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/posts\/76317","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/comments?post=76317"}],"version-history":[{"count":4,"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/posts\/76317\/revisions"}],"predecessor-version":[{"id":76334,"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/posts\/76317\/revisions\/76334"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/media\/76327"}],"wp:attachment":[{"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/media?parent=76317"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/categories?post=76317"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/tags?post=76317"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}